The work of the Partnership is centered on the goal of improving health outcomes for pregnant women and their babies in West Virginia.
The essential source of information upon which the initiatives of the Partnership are based is obtained from the Key Informant Survey. The first Key Informant Survey was conducted in 2006 to gain input from medical, nursing and other individuals serving pregnant women and their babies in both rural and urban areas about their opinions regarding why West Virginia has one of the highest rates of infant mortality and low birth weight babies in the nation.Learn More
Maternal Smoking Before and During Pregnancy and the Risk of Sudden Unexpected Infant DeathMarch 12, 2019
Drug Free Moms and Babies Abstract Presented at APHA 2018 ConferenceFebruary 8, 2019
PUBLICATION: Novel Withdrawal Symptoms of a Neonate Prenatally Exposed to a Fentanyl AnalogJanuary 2, 2019
Thomas Memorial Hospital Introduces Grace’s ClosetDecember 18, 2018
CURRENT NEWS & EVENTS
Treatment Services for Pregnant Women with Substance Use DisordersLearn More
Improving Care for Newborns with Substance Exposure and Neonatal Abstinence Syndrome (NAS)
The West Virginia Perinatal Partnership seeks to provide a better understanding of the extent and cost of the problem of perinatal substance use and to help implement effective interventions to reduce the impact. With funding from the Claude W. Benedum Foundation, and in collaboration with the Department of Health and Human Resources and many other state partners, the Perinatal Partnership is implementing a Quality Improvement initiative aimed at improving the identification, diagnosis and treatment of substance exposed infants in West Virginia.
Improving the identification of Substance Exposed Infants in WV is presented by Sean Loudin, MD of Cabell Huntington Hospital, Stefan Maxwell, MD of CAMC’s Women and Children’s Hospital, and Collin John, MD of Ruby Memorial, West Virginia University.See the Presentation